Boeing Isn't Perfect -- but It's Still a Compelling Value Buy Right Now

Boeing is valued at a substantial free-cash-flow discount to aerospace peers from 2028 onward, trading at 17.1x 2028 FCF and 11.6x 2030 FCF versus 28.3x and 23.1x, respectively, for GE Aerospace. The investment case rests on executing its more than 6,200-aircraft, $597 billion backlog as 737 MAX production ramps toward 47 per month and eventually 52 per month. Supply-chain risk has been reduced through the December 2025 acquisition of Spirit AeroSystems, while Boeing Defense, Space & Security is projected to return to profitability in 2026, though production stability and certification execution remain key risks.

Analysis

BA's apparent 2028-30 FCF discount is less a conventional valuation anomaly than a market-assigned execution haircut: each incremental delivery-rate miss simultaneously defers cash receipts, increases abnormal production cost, and dilutes the high-margin aftermarket installed-base ramp. The key near-term variable is not the announced monthly rate but demonstrated stability—supplier shortages, rework, or FAA quality findings can turn a nominal rate increase into inventory growth rather than cash conversion. This leaves BA highly convex to clean delivery data over the next 1-3 quarters, but unsuitable as a pure long-duration FCF compounder until working-capital release is visible.

Vertical integration of Spirit shifts risk from a distressed supplier relationship onto BA's own balance sheet. That should improve schedule control over 6-18 months, but it also exposes BA to any latent fuselage-quality, labor, and remediation costs that previously sat outside the consolidated P&L; investors should watch segment margins and cash charges rather than assume immediate synergy. HWM, HXL and GE retain relatively cleaner exposure to aerospace build-rate recovery because their pricing and aftermarket economics are less burdened by certification and program-accounting risk.

The underappreciated competitive consequence is that delayed narrowbody availability supports Airbus pricing power and reduces airline bargaining leverage, benefiting AIR more directly than BA from industry capacity scarcity. Conversely, a credible certification and stable-rate inflection would compress the BA/AIR valuation gap quickly, since airlines with deferred fleet renewals have strong incentive to preserve a second source. Consensus appears too focused on the terminal FCF multiple and not enough on whether BDS stops consuming cash; a single additional fixed-price charge would undermine the premise that commercial recovery can fund deleveraging.

Key Decisions for Investors

• Watch, rather than chase, BA ahead of the next two delivery and cash-flow updates. Initiate a tactical long only if deliveries track production for two consecutive months and management reiterates annual FCF guidance; target a 15-20% rerating over 6-12 months, with exit on a renewed FAA production constraint, a BDS charge, or FCF guidance cut.
• Express the cleaner aerospace-cycle view via long GE and HWM versus short BA in equal dollar beta-adjusted size over 3-6 months. This captures engine/component and aftermarket exposure while hedging BA-specific certification, working-capital, and fixed-price-program risk; close if BA demonstrates sustained positive FCF ahead of consensus or if GE/HWM aftermarket guidance weakens.
• For investors requiring BA upside exposure, prefer a 9-12 month call spread financed with an out-of-the-money put spread rather than outright shares until the delivery-to-cash conversion is confirmed. The thesis is a discrete execution rerating, not a smooth earnings trajectory; size risk to a scenario where another quality event produces a 20%+ equity drawdown.
• Maintain AIR as the competitive hedge against a prolonged BA recovery. A widening delivery shortfall should support Airbus backlog conversion and pricing, while a BA certification/rate breakthrough is the falsifier and would argue for taking profits on the AIR relative position.